PET/CT Nuclear Medicine System to Improve Cancer Detection and Treatment in Tunisia
By MedImaging International staff writers Posted on 28 Apr 2016 |
The delivery of the first combined Positron Emission Tomography Computed Tomography (PET/CT) advanced imaging system to Tunisia is set to benefit cancer patients in the country.
The system combines CT technology, which can accurately localize a tumor, with nuclear medicine (PET), which provides radiologists with information about the behavior of the cancer. Cancer mortality is increasing in Tunisia, and it is already the second most common non-infectious disease in the country.
The GE Healthcare (Chalfont St Giles, Buckinghamshire, UK) PET/CT machine was installed at the CERU Nuclear Medicine Center (Tunis, Tunisia). CERU is Tunisia’s largest private center providing clinical radiology, and nuclear medicine treatments. Oncologists are using the new system to monitor and assess therapeutic responses to cancer treatments. GE Healthcare has committed USD1 billion globally to advance oncology solutions in 2016.
The PET/CT system received regulatory authorization by the Tunisian authorities in September 2015, and has already treated more than 100 patients. PET/CT also enables oncologists to track how a patient is responding to treatment, in the early stages of the disease, and change the treatment regime if necessary.
Farid Fezoua, president, and CEO, GE Healthcare in Africa, said, “GE is proud to have been selected by CERU as the key technology provider by for this important program. GE Healthcare is committed to serving its customers through partnerships and solutions offerings aimed at accelerating the development of sustainable healthcare in Tunisia.”
Related Links:
GE Healthcare
CERU Nuclear Medicine Center
The system combines CT technology, which can accurately localize a tumor, with nuclear medicine (PET), which provides radiologists with information about the behavior of the cancer. Cancer mortality is increasing in Tunisia, and it is already the second most common non-infectious disease in the country.
The GE Healthcare (Chalfont St Giles, Buckinghamshire, UK) PET/CT machine was installed at the CERU Nuclear Medicine Center (Tunis, Tunisia). CERU is Tunisia’s largest private center providing clinical radiology, and nuclear medicine treatments. Oncologists are using the new system to monitor and assess therapeutic responses to cancer treatments. GE Healthcare has committed USD1 billion globally to advance oncology solutions in 2016.
The PET/CT system received regulatory authorization by the Tunisian authorities in September 2015, and has already treated more than 100 patients. PET/CT also enables oncologists to track how a patient is responding to treatment, in the early stages of the disease, and change the treatment regime if necessary.
Farid Fezoua, president, and CEO, GE Healthcare in Africa, said, “GE is proud to have been selected by CERU as the key technology provider by for this important program. GE Healthcare is committed to serving its customers through partnerships and solutions offerings aimed at accelerating the development of sustainable healthcare in Tunisia.”
Related Links:
GE Healthcare
CERU Nuclear Medicine Center
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment